[1]
Sommervoll, F. Å. et al. 2026. How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?. Acta Oncologica. 65, (Mar. 2026), 232–240. DOI:https://doi.org/10.2340/1651-226X.2026.45040.